Practical application of minimal residual disease assessment in childhood acute lymphoblastic leukaemia annotation.
Goulden
N
N
University of Bristol and Bristol Children's Hospital, Bristol, UK. nick.goulden@bristol.ac.uk
Oakhill
A
A
Steward
C
C
D000970:Antineoplastic Agents / Q000627:therapeutic use; D001853:Bone Marrow / Q000473:pathology*; D016026:Bone Marrow Transplantation; D002648:Child; D003365:Costs and Cost Analysis; D006801:Humans; D018365:Neoplasm, Residual / Q000473:pathology*; D016133:Polymerase Chain Reaction; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy / Q000473:pathology* / Q000628:therapy; D011237:Predictive Value of Tests; D011379:Prognosis
D000970:Antineoplastic Agents